European shares gain on earnings boost; Novo Nordisk slips

  • 📰 Investingcom
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 53%

United Kingdom News News

United Kingdom United Kingdom Latest News,United Kingdom United Kingdom Headlines

European shares gain on earnings boost; Novo Nordisk slips

- European shares opened higher on Wednesday, as a slew of upbeat corporate earnings lifted sentiment, although gains were capped after heavyweight Novo Nordisk (NYSE:Novo Nordisk dropped 6.6% after the obesity drugmaker posted quarterly operating profit below expectations and also cut its annual profit outlook.

Among other notable moves, car parts maker Continental jumped 5% after it trounced expectations for second-quarter results.Beiersdorf slipped nearly 4% despite the Nivea maker reporting a 7.1% organic sales growth for the first half of the year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 450. in UK

United Kingdom United Kingdom Latest News, United Kingdom United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Shares of Wegovy maker Novo Nordisk slide 7% after earnings missNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: CNBC - 🏆 12. / 72 Read more »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: NBCLA - 🏆 319. / 59 Read more »

Wegovy maker Novo Nordisk posts earnings miss, cuts operating profit outlookNovo Nordisk on Wednesday announced its second quarter earnings for 2024.
Source: CNBC - 🏆 12. / 72 Read more »

Lilly, Novo Nordisk Battle for Weight-loss Market Lands At the Pharmacy ShelfAs Eli Lilly's weight-loss drug Zepbound gains ground in the U.S. against Novo Nordisk's Wegovy, some doctors say their guiding principle for writing prescriptions is...
Source: Medscape - 🏆 386. / 55 Read more »